TY  - JOUR
AU  - Benesova-Schäfer, Martina
AU  - Haberkorn, Uwe
AU  - Babich, John W
TI  - The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer.
JO  - European urology
VL  - nn
SN  - 0302-2838
CY  - Amsterdam [u.a.]
PB  - Elsevier Science
M1  - DKFZ-2026-00143
SP  - nn
PY  - 2026
N1  - #EA:E270# / epub / Perspectives
AB  - Prostate-specific membrane antigen (PSMA)-targeting strategies in prostate cancer have evolved rapidly from early antibody-based approaches to highly effective diagnostic and therapeutic agents. While PSMA remains a central benchmark in metastatic disease, biological heterogeneity and therapy resistance underscore the need for continued innovation and rational combination strategies.
LB  - PUB:(DE-HGF)16
C6  - pmid:41539911
DO  - DOI:10.1016/j.eururo.2026.01.002
UR  - https://inrepo02.dkfz.de/record/308503
ER  -